Retinal Degeneration clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 8 years and up
The overall goal of this project, co-funded by the Foundation Fighting Blindness and the USHER 1F Collaborative is to characterize the natural history of disease progression in patients with PCDH15 mutations in order to accelerate the development of outcome measures for clinical trials.
San Francisco, California and other locations
Our lead scientists for Retinal Degeneration research studies include Jacque Duncan, MD.